IFN-γ treatment significantly induced IFITM1 expression in MPNST cells and xenograft mice, and this IFN-γ-mediated IFITM1 upregulation may have caused the suppression of Ras and ERK1/2 (Figure 3 and Figure 4). The gene discussed is MAPK3; the disease is malignant peripheral nerve sheath tumor.